Synopsys (SNPS): Evaluating Valuation After Recent Share Price Rebound

Synopsys (SNPS) shares have shown some movement over the past month and are currently trading at $404.63. With annual revenue and net income growth both around 16% to 19%, investors may be evaluating the stock’s underlying value.

See our latest analysis for Synopsys.

After a difficult few months, Synopsys shares have rebounded impressively in the past week, gaining real momentum with a 3.7% increase. The 1-month share price return stands at -12.8% and the total shareholder return over 12 months remains down 28%. Long-term holders still see a 5-year total return of nearly 78%, showing the company's enduring strength even through recent volatility.

If Synopsys' recent movement got your attention, it might be the perfect time to explore leading names in tech and AI through our discovery list: See the full list for free.

With the numbers in mind, the key question is whether Synopsys is trading at a bargain given its growth rates or if the market has already factored in its future prospects. Is this a chance to buy in, or is everything already priced in?

Advertisement

Most Popular Narrative: 27.3% Undervalued

Compared to its last closing price of $404.63, the most widely followed narrative sees Synopsys as having a fair value much higher. This suggests the market may be missing some crucial upside potential and provides an opportunity to explore what drives that outlook.

The ongoing transformation towards SaaS/cloud-based EDA and Ansys product integration is expected to increase customer stickiness and shift more revenues to subscription and service models. This improves revenue visibility and earnings consistency, directly addressing operational headwinds and is likely underappreciated if the stock is undervalued.

Read the complete narrative.

Want to know what bold assumptions unlock this much higher fair value? It is not just growth, but a combination of shifting business models and ambitious profitability targets that could push Synopsys well beyond current expectations. Explore the projections that underpin this surprisingly bullish valuation.

Result: Fair Value of $556.40 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, persistent China-related uncertainties and ongoing IP segment headwinds could challenge Synopsys' recovery and limit upside in the near term.

Find out about the key risks to this Synopsys narrative.

Another View: A Look Through the Market Lens

While many see Synopsys as undervalued, its price-to-earnings ratio stands at 64.4x, making it much more expensive than the US Software industry average of 30.4x and also above its estimated fair ratio of 45.2x. This notable gap raises important questions about valuation risk for buyers right now. Which side of the argument do you agree with?

See what the numbers say about this price — find out in our valuation breakdown.

NasdaqGS:SNPS PE Ratio as at Nov 2025
NasdaqGS:SNPS PE Ratio as at Nov 2025

Build Your Own Synopsys Narrative

If you are not convinced by this perspective or want to dig into the numbers yourself, you can craft a personalized Synopsys story in just a few minutes. Do it your way.

A great starting point for your Synopsys research is our analysis highlighting 3 key rewards and 3 important warning signs that could impact your investment decision.

Looking for More Smart Investment Opportunities?

Don't miss your chance to uncover standout investment ideas; just a few thoughtful moves today can put you ahead of the curve tomorrow.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About NasdaqGS:SNPS

Synopsys

Provides design IP solutions in the semiconductor and electronics industries.

Moderate growth potential with mediocre balance sheet.

Advertisement

Weekly Picks

LO
Lou_Basenese
CUE logo
Lou_Basenese on Cue Biopharma ·

Cue Biopharma (NASDAQ: CUE): The Scientist Behind Xolair Just Gave Cue a Next-Generation Shot at the Same Multi-Billion-Dollar Market

Fair Value:US$7056.5% undervalued
25 users have followed this narrative
0 users have commented on this narrative
5 users have liked this narrative
HA
HarishPK
ADBE logo
HarishPK on Adobe ·

Adobe: A Probabilistic Case for Undervaluation

Fair Value:US$317.225.0% undervalued
21 users have followed this narrative
7 users have commented on this narrative
7 users have liked this narrative
NI
niteco
AVGO logo
niteco on Broadcom ·

A Capital Allocation Favorite with Structural Importance

Fair Value:US$651.0539.8% undervalued
18 users have followed this narrative
0 users have commented on this narrative
2 users have liked this narrative
TO
Tokyo
OKTA logo
Tokyo on Okta ·

Good foundation, but now it's all about the next steps

Fair Value:US$15120.6% undervalued
82 users have followed this narrative
7 users have commented on this narrative
11 users have liked this narrative

Updated Narratives

DA
davidlsander
UBI logo
davidlsander on Ubisoft Entertainment ·

Is Ubisoft the Market’s Biggest Pricing Error? Why Forensic Value Points to €33 Per Share

Fair Value:€33.885.3% undervalued
87 users have followed this narrative
7 users have commented on this narrative
0 users have liked this narrative
AN
AntonioS
RFG logo
AntonioS on Retail Food Group ·

Retail Food Group (ASX: RFG) — Deep-Value Thesis

Fair Value:AU$1.250.0% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
BA
Bakullizta
ICBP logo
Bakullizta on Indofood CBP Sukses Makmur ·

Blindly Bullish on Indofood CBP Sukses Makmur's 5.3% Revenue Growth

Fair Value:Rp9.05k30.9% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

MA
martinarauz
NU logo
martinarauz on Nu Holdings ·

Investment Analysis (May 2026)

Fair Value:US$22.7447.8% undervalued
58 users have followed this narrative
0 users have commented on this narrative
15 users have liked this narrative
CL
Clive_Thompson
TTWO logo
Clive_Thompson on Take-Two Interactive Software ·

Take-Two Interactive: The Calm Before the Storm NASDAQ: TTWO Last Price: $242.41 Date: May 15, 2026

Fair Value:US$276.9723.4% undervalued
57 users have followed this narrative
0 users have commented on this narrative
14 users have liked this narrative
NI
niteco
HON logo
niteco on Honeywell International ·

Honeywell - The Demand-Side of the AI Infrastructure

Fair Value:US$320.1932.6% undervalued
48 users have followed this narrative
0 users have commented on this narrative
19 users have liked this narrative